The South & Central America ophthalmology devices market was valued at US$ 3,323.60 million in 2023 and is expected to reach US$ 5,557.30 million by 2031; it is estimated to register at a CAGR of 6.6% from 2023 to 2031.
Ophthalmology device manufacturers are implementing strategies such as strategic alliances, geographic expansions, partnerships, mergers and acquisitions, and product/service launches to mark their presence in the market.
These collaborative efforts and product developments contribute significantly to the growth of the South & Central America ophthalmology devices market.
The South & Central America ophthalmology devices market is segmented into Argentina, Brazil, and the Rest of South & Central America. Brazil is expected to hold the major market share in this region. The Ophthalmology devices market in this region is expected to grow rapidly due to expanding healthcare facilities, rising prevalence of eye disorders, and initiatives taken by various private and public organizations.
Also, the prevalence of eye disease is increasing in Brazil, which can be mainly associated with the growing geriatric population. According to the study titled "Prevalence and associated risk factors for DED among Brazilian undergraduate students," published in November 2021, dry eye symptoms are more prevalent among Brazilian university students compared to the rate recorded among the general Brazilian population aged 40 or more. As stated in the study titled "Prevalence and risk factors for dry eye disease: the Sao Paulo dry eye study" in March 2022, DED prevalence in Sao Paulo city is higher in women than in men. Moreover, hypertension and age were stronger risk factors for DED in women. Therefore, increasing cases of eye disorders propel the ophthalmology devices market growth in Brazil.
The South & Central America ophthalmology devices market is segmented based on product, application, end user, and country.
Based on product, the North America ophthalmology devices market is segmented into vision care products, surgical devices, and diagnostics and monitoring devices. The vision care products segment held the largest share in 2023.
In terms of application, the North America ophthalmology devices market is segmented into cataract, glaucoma, refractory disorders, vitreoretinal disorders, and other applications. The glaucoma segment held the largest share in 2023.
By end user, the North America ophthalmology devices market is segmented into hospital and eye clinics, academic and research laboratories, and other end users. The hospital and eye clinics segment held the largest share in 2023.
Based on country, the South & Central America ophthalmology devices market is categorized into Brazil, Argentina, the Rest of South & Central America. Brazil dominated the South & Central America ophthalmology devices market in 2023.
Key players operating in the South & Central America ophthalmology devices market are Johnson & Johnson Vision Care Inc, Alcon AG, Carl Zeiss Meditec, Bausch & Lomb Inc, Essilor Intonational SAS, Nidek Co Ltd, Topcon Corp, and Hoya Corp are some of the leading companies operating in the South & Central America ophthalmology devices market.